Medavail Holdings Inc

NASDAQ MDVL

Data sourced from

and

Download Data

Medavail Holdings Inc Revenue Per Share for the year ending December 31, 2022: USD 32.77

Medavail Holdings Inc Revenue Per Share is USD 32.77 for the year ending December 31, 2022, a -3.28% change year over year. Revenue per share measures the amount of revenue generated by a company per outstanding share. It is calculated by dividing the revenue by the number of outstanding shares (weighted average). This ratio provides insights into the company's revenue generation on a per-share basis. A higher revenue per share indicates stronger revenue performance and potentially higher value per share for investors.

Medavail Holdings Inc Revenue Per Share for the year ending December 31, 2021 was USD 33.88, a -72.24% change year over year.
Medavail Holdings Inc Revenue Per Share for the year ending December 31, 2020 was USD 122.06, a 1,950.05% change year over year.
Medavail Holdings Inc Revenue Per Share for the year ending December 31, 2019 was USD 5.95, a 293.57% change year over year.
Medavail Holdings Inc Revenue Per Share for the year ending December 31, 2018 was USD 1.51, a -66.21% change year over year.

NASDAQ: MDVL

Medavail Holdings Inc

CEO	Ms. Ramona Seabaugh
IPO Date	May 3, 2010
Location	Canada
Headquarters	6665 Millcreek Drive, Mississauga, ON, Canada, L5N 5M4
Employees	279
Sector	Healthcare
Industry	Pharmaceutical retailers

Description

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Key trends